TRCT
MENS

Tower Research Capital (TRC)’s Jyong Biotech MENS Stock Holding History

Tower Research Capital (TRC)’s Portfolio MENS Stock Details MENS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.21K Sell
1,070
-10,633
-91% -$22.6K ﹤0.01% 4703
2026
Q1 		$25.2K Buy
11,703
+6,918
+145% +$16.9K ﹤0.01% 3318
2025
Q4 		$18.9K Buy
4,785
+4,759
+18,304% +$168K ﹤0.01% 3136
2025
Q3 		$1.02K Buy
+26
New +$936 ﹤0.01% 4892

Other funds holding MENS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Tower Research Capital (TRC)'s MENS Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Jyong Biotech (MENS) stake by 91% in Q2 2026, selling an estimated $22.6K and leaving 1,070 shares worth $2.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4703.

Tower Research Capital (TRC) first reported a position in MENS in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.2K in Q1 2026. 19 funds tracked by Wall St. Rank hold MENS as of Q2 2026.

  • Tower Research Capital (TRC) held 1,070 shares of Jyong Biotech worth $2.21K as of Q2 2026.
  • Tower Research Capital (TRC) sold 10,633 Jyong Biotech shares in Q2 2026, an estimated $22.6K.
  • Jyong Biotech made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #4703 holding.
  • Tower Research Capital (TRC) first reported a position in Jyong Biotech in Q3 2025 and has held it in 4 quarters since.
  • Tower Research Capital (TRC)'s Jyong Biotech position peaked at $25.2K in Q1 2026.
  • 19 funds tracked by Wall St. Rank held Jyong Biotech as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.